Articles tagged with Personalized Medicine
Researchers analyzed DNA sequences and electronic health records of thousands of individuals to discover that the chance a pathogenic genetic variant may cause a disease is relatively low, about 7 percent. However, some variants are linked to wide range of risks for disease.
Roswell Biotechnologies has developed a molecular electronics sensor on a semiconductor chip, enabling real-time detection of single molecules for diverse applications including drug discovery, diagnostics, and DNA sequencing. The platform offers unlimited scalability in sensor pixel density and high resolution measurements.
A new federally funded study will use machine learning to create a first-of-its-kind algorithm predicting individual responses to food and dietary routines. The National Institutes of Health's All of Us Research Program will recruit 10,000 participants nationwide.
A team of scientists at the University of Missouri used small wearable sensors to gather data on how people with a traumatic hand amputation use a prosthesis versus a transplanted hand. The study found that hand transplant recipients exhibit a more balanced pattern of limb use, while prosthesis users rely heavily on their prosthetic hand.
A new consensus statement provides recommendations for the diagnosis, management, and care of individuals with achondroplasia across all life stages. The guidelines aim to improve clinical outcomes and quality of life for those affected by this genetic disorder.
A new study from Karolinska Institutet and the University of Helsinki reveals how integrating digital tools, classical laboratory tests, and biomolecular measurements can enable individualized disease prevention. The researchers also found significant correlations between health risks and molecular factors associated with overweight, d...
A new study found that only alcohol consumption consistently triggers episodes of atrial fibrillation, a common heart condition. The study used an individualized testing method, where participants tested various triggers, including drinking alcohol and caffeine, to find the most effective ways to manage their AF.
A world-first study published in the New England Journal of Medicine found that whole genome sequencing can uncover new diagnoses for people with rare diseases. The pilot study analyzed 4,660 individuals and found a new diagnosis for 25% of participants, including 14% not detectable by other conventional methods.
A systematic review of AI studies on mechanical ventilation found that many were testing early technology, but more work is needed for transparency and bias avoidance. The review recommends improving data availability and reporting standards to facilitate the translation of AI into improved patient care.
Researchers at University of Queensland successfully protected mice from COVID-19 using a US-developed vaccine candidate delivered via a pocket-sized, pain-free applicator. The vaccine produced strong immune responses and neutralized multiple variants, including UK and South Africa variants.
A five-year study aims to identify hormone responses in a population of Mexican Americans with prediabetes, Type 2 diabetes, and obesity. The research uses genetic data and physiologic testing to guide optimal treatments for diabetes, prediabetes, and related diseases.
The Comparing Outcomes of antibiotic Drugs and Appendectomy (CODA) trial found that nearly 7 in 10 patients with antibiotics avoided an appendectomy within three months. By four years, just under 50% had the surgery, suggesting both treatments are safe and valuable to patients differently based on unique symptoms and circumstances.
A research team from the University of Zurich has identified a common genetic variant in the AQP1 gene that affects treatment efficacy and patient survival on peritoneal dialysis. Patients carrying this variant have a higher risk of death, but researchers found a way to circumvent the problem using colloid osmotic agents.
The University of Ottawa has launched the Interdisciplinary Centre for Black Health (ICBH), a leading research center examining biological, social, economic, and cultural determinants of Black health. The ICBH aims to identify priorities in research on physical and mental health disparities among Canada's Black communities.
The new ESMO Clinical Practice Guideline provides comprehensive guidance on diagnosing, staging, and treating patients with metastatic breast cancer. The guideline incorporates recent clinical trial data to inform treatment choices, taking into account tumour biology and emerging targeted therapies.
Researchers found that high levels of immune cells in tumors correlate with better outcomes for esophageal cancer patients. The study used the Immunoscore to evaluate tumor-infiltrating lymphocytes and found a strong association between high scores and long-term survival rates.
Researchers identify key neurons and signaling pathway regulating female activity before ovulation. Discoveries could lead to new treatments for menopause that sidestep estrogen and reactivates the circuit with CRISPRa technology.
Researchers conducted genomic evaluations of advanced malignancies to develop matched, individualized combination therapies. The study found that precision cancer therapy improved median overall survival rate by 3.9 months compared to standard care.
Researchers conducted a functional test to identify effective therapies for advanced hematological cancers, achieving significant positive outcomes with 56 patients receiving individually tailored treatment. The study demonstrates the clinical feasibility and efficacy of personalized medicine in breaking resistance to prior therapies.
A University of Alberta-led study found that anemia can generate different immune responses in males versus females, making females more prone to infections. The research highlights the importance of considering sex as a variable in prevention, diagnostic, and therapeutic strategies for immune-related conditions.
Researchers have developed a federated analytics system, FAMHE, that enables healthcare providers to collaborate on statistical analyses and machine learning models without exchanging underlying datasets. The system has been proven mathematically secure and accurately reproduced published studies in multi-centric settings.
Researchers at the University of Arizona have created custom-fitted wearable devices that can monitor physiological parameters without needing recharging. The biosymbiotic devices use wireless power transfer and compact energy storage to enable continuous operation, providing accurate data on body temperature, strain, and muscle deform...
Researchers created a customized device that targets unique brain circuits associated with depression, providing immediate relief. The approach uses neural biomarkers to personalize therapy and has shown long-term efficacy in treatment-resistant patients.
Researchers create a novel magnetoelastic generator that can convert human body motions into electricity, outperforming existing technology. The device is flexible, waterproof, and generates significant electrical currents, opening up new avenues for wearable and implantable diagnostic sensors.
Researchers mapped cancer through protein interactions, revealing biomarkers and potential new treatments for breast and head and neck cancers. The study provides a new definition of biomarkers based on large, multi-protein complexes, offering a more precise way to explain mutation effects.
The MAP Virtual Congress 2021 focuses on integrating tumour sample analysis into daily practice, enabling personalized treatment. Key findings include actionable mutations in patient DNA and the role of the tumour microenvironment in metastasis.
New targeted therapies are being developed to target genetic alterations in cancer cells, such as the ARID1A mutation found in 10-50% of solid tumours. Early clinical trials suggest that these agents may be effective in treating multiple cancers, including breast, ovarian, and gastric cancer.
The VCU Massey Cancer Center has established a Translational Research Center in Lung Cancer Disparities (TRACER) to address racial disparities in lung cancer. TRACER will investigate the interaction between stress, smoking, and gene expression to raise lung cancer risk in Black men.
A survey of 5,589 cancer patients found widespread unawareness about immunotherapy's mechanism, efficacy, and cost. Non-oncology doctors also face challenges in keeping up with the latest developments in oncology.
A new algorithm, Phe2vec, accurately identified patients with certain diseases, outperforming traditional methods in classifying diagnoses. The study suggests that this automation will facilitate further research in clinical informatics.
Researchers at Texas A&M University designed a new framework to create the most optimal oxygen concentrator, capable of producing high-purity oxygen and adapting to changing patient needs. The LiLSX-based system outperformed other zeolites in simulation tests.
A pan-Canadian randomized controlled trial is using digital communication to target common reasons for vaccine hesitancy, including age, language, and education level. Family physicians will receive tailored information to share with patients through email and text message, aiming to improve vaccine uptake.
Researchers at RMIT University have discovered a Teflon-like molecule on the womb's surface that decreases at a certain point in the menstrual cycle, opening the 'golden window' for pregnancy success. This finding could lead to improved IVF success rates and potentially treat underlying causes of infertility.
Fels and Fox Chase researchers found specific TET2 and DNMT3A mutations in leukemia patients that affect DNA repair pathways. These mutations make leukemia cells sensitive to PARP inhibitors, a type of targeted therapy, while others are resistant. The study aims to develop personalized therapies for patients with these mutations.
Researchers discovered that almost half of patients who received personalized information about community resources shared them with at least one other person. Individuals in poorer health were more likely to report sharing the information, and those who visited or used a resource on their list were also more likely to share it.
A new app called selfBACK has been developed to help people deal with back pain in a better way. The app uses artificial intelligence and draws on other people's experiences with back pain to provide tailored advice and feedback.
Researchers at University of Colorado Boulder have developed a blood test that can assess the timing of an individual's internal circadian clock, potentially leading to personalized medicine breakthroughs. The study found that analyzing a combination of molecules in a single blood draw can determine the timing of a person's biological ...
Researchers developed a comprehensive tool to explore disease development patterns, identifying main highways of disease progression. The Danish Disease Trajectory Browser analyzes 25 years of public health data to discover frequent disease trajectories.
Scientists have developed biocompatible TeSex nano-alloys that eliminate toxicity and enhance theranostic performances for precision medicine. The nano-alloys enable high-efficacy photothermal therapy under multimodal imaging guidance.
The human genome's complexity hinders personalized medicine by having an immense ability to change and cope with issues, context matters in our genome. Researchers conclude that precision medicine is crucial but must consider the full genomic blueprint including 'unnecessary' elements.
CURATE.AI is an AI-derived mechanism-independent technology platform that profiles individual patients based on their data and recommends optimal drug doses. This approach aims to improve treatment efficacy while reducing toxicity levels and addressing the challenges of personalized dosing.
Researchers have developed a method to monitor and predict the progression of atrial fibrillation using cardiac electrical signals from implantable devices. This technology enables personalized treatment timing, optimizing medical intervention for individual patients.
This special issue focuses on advancements in technologies that enable predictive, preventative, and personalized medicine. The articles cover various topics such as biomicrofluidic systems, purification and enrichment of extracellular vesicles, and electrochemical sensors.
A study by San Diego State University researcher Rob Edwards found a country-specific biomarker for the crAssphage virus in humans, which rapidly changes with travel. The research analyzed over 32,000 sequences from 65 countries and revealed the phage's global distribution.
New research highlights the importance of diverse genetic data in understanding complex traits and diseases. By studying a large number of groups together, scientists have discovered dozens of discoveries that would not have been possible in single-population studies.
The EU-STANDS4PM forum aims to develop standardized transnational frameworks for data integration and in silico modeling in personalized medicine. This will facilitate the use of life science data in clinical research and accelerate growth of the European data-driven economy.
A review paper highlights the transformative potential of precision and personalized medicine for cancer treatment. The traditional approach focuses on general treatments, while PPM allows for individualized treatments tailored to specific tissues and gene mutations.
The Quadratic Phenotypic Optimization Platform (QPOP) uses AI to analyze small datasets and design optimal drug combinations based on real experimental data. This approach can optimize and personalize combination therapy for individual patients with complex diseases, such as multiple myeloma.
A KAIST research team has developed a flexible drug delivery device with controlled release, blurring the path toward theragnosis. The device boasts fewer side effects and uniform therapeutic results compared to oral ingestion, making it suitable for smart contact lenses and brain disease treatments.
The research aims to assess the cost-effectiveness of LHSC's personalized medicine program, which uses pharmacogenomics to predict patient responses to medications. The study will compare patient outcomes with those in the province using provincial health care data.
Researchers have developed a novel omics tool to explore the interaction between genetics, environment, and disease. By integrating large datasets from the BXD mouse population, scientists can identify gene-phenotype associations and make personalized treatment predictions.
Computational biologists discover that protein variations have a significant impact on cell functions, even in healthy individuals. The study's findings could lead to advances in personalized medicine and better understanding of individual responses to environmental influences.
A new study found that generous health insurance plans with low deductibles and copays can lead to unnecessary treatments for chronically ill patients. The study suggests that personalized medicine interventions, providing more information about treatment effectiveness, can reduce healthcare costs and improve patient outcomes.
Researchers have developed a new approach to create integration-free, Myc- and Lin28-free human induced pluripotent stem cells. This breakthrough method reduces the neoplastic risk associated with IPSC generation, enabling their utility in regenerative medicine and personalized medicine.
Personalized Medicine in Psychiatry aims to increase treatment efficacy and reduce adverse effects by considering individual patient characteristics. The journal will publish research on endophenotypes, pharmacologic approaches, and education, with the goal of identifying predictors of response and tailoring treatments.
Seventy percent of patients who kept their gallbladders despite experiencing biliary pancreatitis had no recurrence four years later. A large database analysis found that many patients who did not undergo surgery within 30 days still had no recurrences over a four-year follow-up period.
Researchers at Boston University School of Medicine have developed a novel approach to generate airway cells from stem cells using the Wnt signaling pathway. These cells can be grown into three-dimensional spheres and used to study lung diseases such as cystic fibrosis.
Researchers have discovered significant differences in cells derived from dura mater and skin samples across the lifespan, highlighting the importance of considering the cell's original location and donor age. These findings necessitate further exploration into epigenetic patterns in stem cells used for new tissue and organ generation.
A global research team has identified 52 genetic variants associated with age-related macular degeneration (AMD), a disease affecting 150 million people worldwide. The discovery may lead to personalized medicine approaches and new treatments for this debilitating condition.
More than 120 US engineering schools pledged to graduate 20 'Grand Challenge Engineers' per year, trained through special programs with a focus on hands-on research, global perspectives, and service-learning. The goal is to train over 20,000 engineers to address societal challenges.